Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Apply
WEF-001
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step